Chintan Dave, a core faculty member of the Center for Pharmacoepidemiology and Treatment Science at Rutgers Institute for Health, Health Care Policy and Aging Research, told Newsweek that patients should not stop or reconsider GLP-1 medications solely because of this potential risk
Even so, prior studies suggest that up to 65 % of patients discontinue them within a year, and discontinuation has been associated with weight regain and reduced cardiometabolic benefits
Evidence Rating Level: 1 (Excellent) Study Rundown: Over two-thirds of Americans are considered to be in the overweight or obese body-mass index (BMI) ranges
In the SURMOUNT-1 trial, tirzepatide demonstrated even more substantial results, with some participants losing over 20% of their starting weight
However, if youve been considering Ozempic for weight loss, its important to know that there are effective FDA-approved alternatives available for chronic weight management, which utilize the same groundbreaking science
While telehealth can offer numerous benefits, such as increased accessibility and convenience, it is important to recognize that there are also potential risks associated with its use
